CLPBF (Coloplast AS) Ending Cash Position: $165 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLPBF Coloplast AS CLPBF
77 GF Score
Price $64.00
GF Value $126.13
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Coloplast AS Ending Cash Position?

Coloplast AS CLPBF 77 Ending Cash Position is $165 Mil as of Mar. 2026. GuruFocus rates CLPBF with a GF Score™ of 77/100 and a GF Value™ of $126.13 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Coloplast AS's Ending Cash Position for the quarter that ended in Mar. 2026 was $165 Mil.

Coloplast AS's quarterly Ending Cash Position increased from Sep. 2025 ($149 Mil) to Dec. 2025 ($176 Mil) but then declined from Dec. 2025 ($176 Mil) to Mar. 2026 ($165 Mil).

Coloplast AS's annual Ending Cash Position declined from Sep. 2023 ($130 Mil) to Sep. 2024 ($117 Mil) but then increased from Sep. 2024 ($117 Mil) to Sep. 2025 ($149 Mil).

Coloplast AS Ending Cash Position Related Terms

Coloplast AS Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Ending Cash Position Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.88 55.08 130.37 117.30 148.92

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.66 112.25 148.92 176.38 165.04
CLPBF
77GF Score
Coloplast AS CLPBF
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Coloplast AS's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=116.37+32.553
=149

Coloplast AS's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=174.47+-9.435
=165

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $165 Mil mean?
Coloplast AS (CLPBF) has a Ending Cash Position of $165 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Coloplast AS and its competitors.
Is Coloplast AS's Ending Cash Position too high?
Coloplast AS's current Ending Cash Position is $165 Mil. Overall, Coloplast AS has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Ending Cash Position compare to ISRG and BDX?
Coloplast AS's Ending Cash Position of $165 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Coloplast AS and its competitors. Coloplast AS's current Ending Cash Position is $165 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.13, compared to a current price of $64.00 — trading 49.3% below its estimated fair value. The current Ending Cash Position is $165 Mil. Coloplast AS's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Ending Cash Position is $165 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (CLPBF) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $64.00 is trading 49.3% below its estimated GF Value™ of $126.13. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBF:

  • Ending Cash Position: $165 Mil
  • GF Value™: $126.13 vs. price of $64.00 (49.3% below fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
77GF Score

Get the complete analysis for CLPBF

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$64.00
Price
$126.13
GF Value